Antagonizing SIRT1 activity using inhibitors such as EX527, sirtinol, and the tenovins has been demonstrated to induce p53-mediated apoptosis [27–29], suggesting that SIRT1 inhibition may be beneficial for treating certain types of cancer. Here, TP53 is linked to cancer.